Dopamine-responsive dystonia
| Dopamine-responsive dystonia | |
|---|---|
| Synonyms | Segawa syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Muscle contractions, tremor, gait abnormalities |
| Complications | N/A |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutations in GCH1, TH, or SPR genes |
| Risks | Family history |
| Diagnosis | Clinical evaluation, genetic testing, levodopa trial |
| Differential diagnosis | Cerebral palsy, Parkinson's disease, dystonia |
| Prevention | N/A |
| Treatment | Levodopa, dopamine agonists |
| Medication | N/A |
| Prognosis | Good with treatment |
| Frequency | Rare |
| Deaths | N/A |
Dopamine-responsive dystonia (DRD) is a neurological disorder that affects the nervous system and causes muscle stiffness and involuntary muscle contractions. It is a rare condition that typically begins in childhood and can lead to significant physical disability.
Symptoms[edit]
The symptoms of dopamine-responsive dystonia can vary greatly from person to person. They typically begin in childhood and may include:
- Muscle stiffness
- Involuntary muscle contractions
- Tremors
- Difficulty walking
- Speech difficulties
- Depression
- Anxiety
Causes[edit]
Dopamine-responsive dystonia is caused by a deficiency of the neurotransmitter dopamine in the brain. This can be due to a genetic mutation in the GCH1 gene, which is involved in the production of dopamine. However, in some cases, the cause of the condition is unknown.
Diagnosis[edit]
Diagnosis of dopamine-responsive dystonia is based on the presence of characteristic symptoms and a positive response to treatment with levodopa, a medication that increases the levels of dopamine in the brain. Genetic testing may also be used to confirm the diagnosis.
Treatment[edit]
Treatment for dopamine-responsive dystonia primarily involves medication to increase the levels of dopamine in the brain. This typically includes levodopa and carbidopa, which are often effective in reducing symptoms. In some cases, other medications or therapies may be used.
Prognosis[edit]
With appropriate treatment, most individuals with dopamine-responsive dystonia can lead normal lives. However, the condition is chronic and requires ongoing management to control symptoms.
See also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


